vip
Regeneration vs degeneration — where this fits
The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.
Why it would work (logic chain)
No mechanism chain catalogued yet.
How many people take it
There is no reliable global count of how many people take this compound. That number is not in this ledger.
What we can count from this ledger:
- 0 anecdote source(s) (posts, threads, comments)
- 0 anecdote-tier claim(s) derived from them
Logic: Without catalogued Reddit/X posts, this article cannot answer how many people take it — only what studies exist.
Evidence inventory
This is a count of what is in this ledger — not a claim about all research worldwide.
- Scientific sources catalogued (PubMed, trials, reviews): 12
- Claims tagged human evidence: 0
- Claims tagged preclinical (animal/lab): 0
- Claims tagged anecdotal: 0
- Reddit posts catalogued: 0
- X posts catalogued: 0
- Other anecdote sources (YouTube, Instagram, etc.): 0
- Total sources in chain: 12
Logic: Studies exist in the ledger, but none are graded as strong human proof for the uses people discuss online. Animal and lab work is not the same as proof in people.
Logic: No social posts catalogued yet — we cannot report what people are saying on Reddit or X from this ledger.
Quantified confidence (this ledger): 0.25 / 1.00 — low — animal and anecdote heavy
Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.
What scientists say
Elevated vasoactive intestinal peptide concentrations ... (source s1)
Elevated VIP not predictive of VIPoma in most cases (2026 study).
Evidence type: Published research.
Serum Vasoactive Intestinal Peptide as a Novel Biomarker ... (source s2)
Serum VIP as potential biomarker for left ventricular areas in AF (2025).
Evidence type: Published research.
Vasoactive intestinal peptide advances chondrogenesis ... (source s3)
VIP promotes chondrogenic differentiation (2026).
Evidence type: Published research.
Neuron-specific overexpression of human vasoactive ... (source s4)
Overexpression of VIP receptor 2 linked to cognitive issues in mice (2026).
Evidence type: Published research.
Neuronal VIP wires the intestinal epithelial cell function (source s5)
Neuronal VIP regulates gut epithelial and immune function (2026).
Evidence type: Published research.
Myopia pathogenesis and vasoactive intestinal peptide: Molecular mechanisms, experimental models, and clinical implications (source s6)
2026 review on VIP/VIPR2 role in myopia pathogenesis, models, and therapeutic potential.
Evidence type: Published research.
Vasoactive intestinal peptide associated 8-gene signature with prognostic and immune associations in melanoma (source s7)
2026 study develops VIP-related 8-gene prognostic signature in melanoma linked to immune microenvironment.
Evidence type: Published research.
Stress-type specific changes of VIP signaling in limbic brain areas (source s8)
Discusses stress-type specific changes in VIP signaling in limbic areas.
Evidence type: Published research.
Neuronal VIP shapes intestinal stem cell activity and regeneration (source s9)
Neuronal VIP regulates intestinal stem cells and regeneration.
Evidence type: Published research.
Vasoactive Intestinal Peptide Induces Autophagy and Cytotoxicity in Renal Cell Carcinoma via SIRT3-Dependent Signaling Pathway (source s10)
VIP induces autophagy and cytotoxicity in renal cell carcinoma.
Evidence type: Published research.
Dorsal Raphe VIP Neurons Are Critical for Survival and Adaptive Responses to Threat (source s11)
Dorsal raphe VIP neurons critical for threat responses.
Evidence type: Published research.
Motor Cortex VIP Interneurons Participate in Diurnal Regulation of Motor Activity (source s12)
Motor cortex VIP interneurons in diurnal motor activity regulation.
Evidence type: Published research.
---
Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.
Ask this article · 2 suggested prompts
Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.